Sarı Türk, Sibel

Loading...
Name Variants
Sari, Sibel Sarı, Sıbel Sibel Sarı
Job Title
Dr. Öğr. Üyesi
Email Address
sibel.sari@agu.edu.tr
Main Affiliation
04.02. Moleküler Biyoloji ve Genetik
Status
Current Staff
Website
Scopus Author ID
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID
No research topics data found.

Sustainable Development Goals

NO POVERTY1
NO POVERTY
0
Research Products
ZERO HUNGER2
ZERO HUNGER
0
Research Products
GOOD HEALTH AND WELL-BEING3
GOOD HEALTH AND WELL-BEING
2
Research Products
QUALITY EDUCATION4
QUALITY EDUCATION
0
Research Products
GENDER EQUALITY5
GENDER EQUALITY
0
Research Products
CLEAN WATER AND SANITATION6
CLEAN WATER AND SANITATION
0
Research Products
AFFORDABLE AND CLEAN ENERGY7
AFFORDABLE AND CLEAN ENERGY
0
Research Products
DECENT WORK AND ECONOMIC GROWTH8
DECENT WORK AND ECONOMIC GROWTH
0
Research Products
INDUSTRY, INNOVATION AND INFRASTRUCTURE9
INDUSTRY, INNOVATION AND INFRASTRUCTURE
0
Research Products
REDUCED INEQUALITIES10
REDUCED INEQUALITIES
0
Research Products
SUSTAINABLE CITIES AND COMMUNITIES11
SUSTAINABLE CITIES AND COMMUNITIES
1
Research Products
RESPONSIBLE CONSUMPTION AND PRODUCTION12
RESPONSIBLE CONSUMPTION AND PRODUCTION
1
Research Products
CLIMATE ACTION13
CLIMATE ACTION
0
Research Products
LIFE BELOW WATER14
LIFE BELOW WATER
1
Research Products
LIFE ON LAND15
LIFE ON LAND
0
Research Products
PEACE, JUSTICE AND STRONG INSTITUTIONS16
PEACE, JUSTICE AND STRONG INSTITUTIONS
0
Research Products
PARTNERSHIPS FOR THE GOALS17
PARTNERSHIPS FOR THE GOALS
0
Research Products
This researcher does not have a Scopus ID.
This researcher does not have a WoS ID.
No records found in other affiliations.
Scholarly Output

2

Articles

1

Views / Downloads

0/5

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

0

Scopus Citation Count

0

Patents

0

Projects

0

WoS Citations per Publication

0.00

Scopus Citations per Publication

0.00

Open Access Source

1

Supervised Theses

0

JournalCount
Sustainable Pharmaceutical Product Development and Optimization Processes: From Eco-Design to Supply Chain Integrity1
Türk Doğa ve Fen Dergisi1
Current Page: 1 / 1

Scopus Quartile Distribution

Quartile distribution chart data is not available

Competency Cloud

GCRIS Competency Cloud

Scholarly Output Search Results

Now showing 1 - 2 of 2
  • Book Part
    Sustainable Strategies for Cancer Phytomedicine: Balancing Efficacy and the Environment Responsibility
    (Springer Nature, 2025) Sari, Sibel; Saylan, Demet
    Cancer is a complex disease, with approximately six million new cases reported annually. Despite the numerous treatment strategies employed worldwide, the severity of cancer continues to increase. Conventional cancer treatments, such as surgery, radiotherapy, and chemotherapy, are standard practices, but their clinical success is constrained by toxic side effects leading to damage to healthy tissues, unavoidable off-target effects, and significant cancer recurrence resulting from incomplete surgical removal. Therefore, interest in alternative therapies sourced primarily from natural products is increasing. The popularity of phytomedicine in cancer treatment approaches is increasing because of its efficacy, affordability, accessibility, and minimal adverse effects. Additionally, green chemistry approaches can be used to synthesize a wide array of anticancer drugs with various chemical structures, enhancing their therapeutic efficacy while minimizing or eliminating side effects and toxicity. The enhanced efficacy of cancer medicines made from plants is achieved via molecular innovations that support precise targeting. Various drug delivery systems that aim to reduce environmental pollution while reducing waste can be optimized for better results in therapy through nanotechnology. The delivery of effective cancer therapies while preserving the environment for generations to come is the objective of this approach, which includes green chemistry, sustainable production, and molecular developments. © 2025 Elsevier B.V., All rights reserved.
  • Article
    Aurora Kinases: Their Role in Cancer and Cellular Processes
    (2024-06-28) Sarı, Sıbel; Özsoy, Elif Rumeysa
    Aurora kinazlar, Aurora A, B ve C şeklinde tanımlanan üç üyeye sahip, hücre döngüsünün düzenlenmesinde kritik rolleri olan yüksek oranda korunmuş serin/treonin kinaz ailesine ait proteinlerdir. Aurora kinazlar, kromozom stabilitesinin korunmasında önemli rolleri olan mitotik düzenleyiciler olarak hizmet etmektedir. Mitozdaki çeşitli olaylarda kritik roller üstlenen Aurora kinazlar, kromozomal ve sitoskeletal olayların koordinasyonu, iğ ipliği oluşumu kontrolü ve sitokinez gibi olaylarda görev alarak hücre döngüsünün sorunsuz ilerlemesini sağlamaktadır. Mitotik fonksiyonlarının yanı sıra, Aurora kinazlar mayoz bölünmenin düzenlenmesi süreçlerinde de yer almaktadırlar. Aurora kinazların gen amplifikasyonu/mutasyonu ve aşırı ifadesi çeşitli solid ve hematolojik kanserlerde tespit edilmiştir. Aurora kinazlar mitotik rolleri ile ilişkilendirilen onkojenik fonksiyonları ile kanser hücrelerinin çoğalması ve hayatta kalmalarını sağlamaktadırlar. Aurora kinaz aktivitesinin bozulması, sentrozom fonksiyonunda, iğ ipliklerinin oluşumunda, kromozomal hizalanmada ve sitokinezde sorunlara neden olarak mitotik anormallikler ve genetik istikrarsızlığa yol açmaktadır. Bu bulgular, Aurora kinazların kanserdeki önemli fonksiyonlarını vurgulayarak kanser terapötikleri için değerli hedefler olarak tanınmalarını sağlamaktadır. Bu derleme, Aurora kinazların yapı ve fonksiyonlarına genel bir bakış sunarak, bu kinazların kanserdeki onkojenik rollerini aydınlatmaktadır.